# Peregrine Pharmaceuticals (now Avid Bioservices)

Source: https://onco.cc/companies/peregrine-avid/  
OnCo record `peregrine-avid` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Peregrine was a Californian biotech whose phosphatidylserine antibody bavituximab failed a phase 3 lung cancer trial; the company kept its contract manufacturing arm and became Avid Bioservices.

## Summary

Peregrine Pharmaceuticals, based in Tustin, California, developed bavituximab, an antibody against phosphatidylserine exposed on tumour blood vessels, and took it into the phase 3 SUNRISE trial in non-small cell lung cancer, which was stopped for futility in 2016. The company then concentrated on its contract development and manufacturing business and renamed itself Avid Bioservices in 2018. The bavituximab trials remain on ClinicalTrials.gov under the Peregrine name.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Peregrine Pharmaceuticals; Peregrine Pharmaceuticals, Inc.; Avid Bioservices
- Tags: ctgov-sponsor
- HQ: Tustin, CA
- Type: biotech
- Website: https://www.avidbio.com

## Sources

- Official website: https://www.avidbio.com
- ClinicalTrials.gov: trials led by Peregrine Pharmaceuticals: https://clinicaltrials.gov/search?lead=Peregrine%20Pharmaceuticals
- Wikidata: https://www.wikidata.org/wiki/Q30288606

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)

---
JSON: https://onco.cc/api/v1/entities/peregrine-avid.json